These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 35773731)

  • 1. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention.
    Mirzaei S; Paskeh MDA; Okina E; Gholami MH; Hushmandi K; Hashemi M; Kalu A; Zarrabi A; Nabavi N; Rabiee N; Sharifi E; Karimi-Maleh H; Ashrafizadeh M; Kumar AP; Wang Y
    J Exp Clin Cancer Res; 2022 Jul; 41(1):214. PubMed ID: 35773731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
    Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long non-coding RNAs in prostate cancer: An update].
    Wu PG; Zhang YX
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
    Mirzaei S; Paskeh MDA; Hashemi F; Zabolian A; Hashemi M; Entezari M; Tabari T; Ashrafizadeh M; Raee P; Aghamiri S; Aref AR; Leong HC; Kumar AP; Samarghandian S; Zarrabi A; Hushmandi K
    Life Sci; 2022 Jan; 288():119948. PubMed ID: 34520771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
    Entezari M; Taheriazam A; Orouei S; Fallah S; Sanaei A; Hejazi ES; Kakavand A; Rezaei S; Heidari H; Behroozaghdam M; Daneshi S; Salimimoghadam S; Mirzaei S; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Oct; 154():113609. PubMed ID: 36037786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome.
    Yarmishyn AA; Batagov AO; Tan JZ; Sundaram GM; Sampath P; Kuznetsov VA; Kurochkin IV
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S7. PubMed ID: 25522241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
    Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation.
    Tonmoy MIQ; Fariha A; Hami I; Kar K; Reza HA; Bahadur NM; Hossain MS
    Sci Rep; 2022 Jun; 12(1):10260. PubMed ID: 35715447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
    Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
    Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
    Li ZF; Xiao N; Yao YW; Yao ZF
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers.
    Ke Z; Hu X; Liu Y; Shen D; Khan MI; Xiao J
    Crit Rev Oncol Hematol; 2024 Apr; 196():104275. PubMed ID: 38302050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer.
    Zhou H; Wan H; Feng Y; Zhu L; Mi Y
    Clin Transl Oncol; 2023 Mar; 25(3):592-600. PubMed ID: 36266385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer-associated lncRNAs.
    Mitobe Y; Takayama KI; Horie-Inoue K; Inoue S
    Cancer Lett; 2018 Apr; 418():159-166. PubMed ID: 29330107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.